Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

A nationwide analysis of readmission rates after colorectal cancer surgery in the US in the Era of the Affordable Care Act. American journal of surgery Kim, J. W., Mannalithara, A. n., Sehgal, M. n., Mithal, A. n., Singh, G. n., Ladabaum, U. n. 2020

Abstract

The Hospital Readmissions Reduction Program (HRRP), which was instituted in 2012, may have affected readmission rates for non-target conditions, including colorectal cancer (CRC). We aimed to analyze the nationwide all-cause 30-day readmission rate following CRC surgery in a US nationwide database.We queried the 2010-2015 Nationwide Readmissions Database to estimate readmission rates. All results were weighted for national estimates.Among 616,348 index cases, the overall 2010-2015 30-day readmission rate was 14.7% (95% confidence interval, 14.5%-14.9% [n = 90,555]), with a decreasing trend from 15.5% in 2010 and 2011 to 13.5% in 2015 (p-trend<0.001). Rectal resection, longer length of stay, non-invasive cancer, surgery at a metropolitan teaching hospital, non-routine discharge, elective admission, and higher Elixhauser comorbidity score were associated with subsequent readmission.In the US, 30-day readmission rates after CRC surgery showed a decreasing trend during 2010-2015, which could represent a spillover effect of the HRRP.

View details for DOI 10.1016/j.amjsurg.2020.04.013

View details for PubMedID 32362379